His experience also includes M&A and corporate development at LogicBio Therapeutics ... creating a robust pipeline targeting CNS, neuromuscular and eye diseases. Headquartered in Paris, France ...

His experience also includes M&A and corporate development at LogicBio Therapeutics, where he supported the ... in gene therapy delivery to extra-hepatic tissues, creating a robust pipeline targeting ...

while integrating best-in-class expertise to accelerate promising therapeutics into the clinic," he remarked. AZ already has one clinical-stage genomic medicine acquired, along with LogicBio ...

This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Sterol 14 Alpha-Demethylase Inhibitor development. The report ...

This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Sterol 14 Alpha-Demethylase Inhibitor development. The report provides ...

May 08, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq ... today announced pipeline progress and business updates and reported financial results for the first quarter ended March ...

Discover Anika Therapeutics' Q1 2025 highlights: strategic pipeline advancements, 18% growth in commercial revenue, and plans for Hyalofast & ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

His experience also includes M&A and corporate development at LogicBio Therapeutics, where he supported the company’s acquisition by Alexion and multiple licensing partnerships. Romain holds dual ...